Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutations.
作者信息
Barsotti Anthony M, Ryskin Michael, Rollins Robert A
机构信息
Oncology Research Unit, Pfizer Worldwide Research & Development, Pearl River, NY 10965, USA.
Kadmon Pharmaceuticals, New York, NY 10016, USA.
出版信息
Epigenomics. 2015 Aug;7(5):687-90. doi: 10.2217/epi.15.27. Epub 2015 Aug 28.
PMID:26317265
Abstract
摘要
Zotero 插件